Javier Mar, MD PhD

JAD profile

Affiliation(s): 

Clinical Management Unit. Alto Deba Hospital. Mondragon. Spain.; Health Services Research on Chronic Patients Network (REDISSEC).Kronikgune group. Spain; Biodonostia Health Research Institute; San Sebastian-Donostia; Spain

Areas of Interest: 

economic evaluation, neurological diseases, Alzheimer's disease, chronic diseases, health policies evaluation, burden of disease

Biography & Research: 

Javier Mar is a Scientific Director of the Clinical Management Unit, Hospital Alto Deba, Arrasate-Mondragón, Gipuzkoa, Spain. He received his MD in 1979 and PhD in 1989 from the University of Navarra, Navarra, Spain, and completed the Txagorritxu Hospital Family and Community Medicine programme in 1983. He has worked in the Clinical Management Unit of the Hospital Alto Deba for the last 22 years. He completed a residency in Community and Family Medicine, followed by four years as General Practitioner, and five years as Medical Director. He completed research in the Clinical Decision Making Division at Tufts-New England Medical Center, Boston, MA, USA, as well as at the University of Glasgow October and November of 2014, funded by the Institute Carlos III. His research interests are in epidemiology and the economic evaluation of diagnostic and therapeutic clinical decision-making, particularly in neurological and chronic diseases. He is specialized in the development and application of population models built with discrete event simulation (DES) and Markov models to cost-effectiveness and budget impact analyses of health programs, and recently the application DES modeling to epidemiological studies to simulate clinical or epidemiological processes that cannot be observed, as early stages of Alzheimer’s disease. He has applied this approach to thrombolysis for stroke, the use of hyaluronic acid in knee osteoarthritis, Alzheimer’s disease, breast cancer screening, hepatitis C, obesity, and bariatric surgery. He has been author or lead author of 65 articles in peer-reviewed journals, and is Member of the Society for Medical Decision Making (SMDM), the Spanish Society of Epidemiology (SSE), and the Spanish Health Economic Association (AES).